APTO
Aptose Biosciences Inc
Halal Rating :
Last Price
$0.21
Last updated:
Market Cap
-
7D Change
-1.32%
1 Year Change
-89.41%
Company Overview
Industries
Exchange
Next Earnings Date
Aptose Biosciences Inc. is a clinical-stage biotechnology company focused on developing precision medicines addressing unmet medical needs in oncology. The company is developing targeted medicines for the treatment of various forms of cancer, including acute myeloid leukemia (AML) and other hematologic malignancies. Their lead clinical candidates include tuspetinib (HM43239) and luxeptinib.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Aptose Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.